[Federal Register: August 4, 1999 (Volume 64, Number 149)]
[Notices]               
[Page 42414]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04au99-102]                         

-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-364 (Review)]

 
Aspirin From Turkey

Determination

    On the basis of the record <SUP>1</SUP> developed in the subject 
five-year review, the United States International Trade Commission 
determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 
U.S.C. 1675(c)) (the Act), that revocation of the antidumping duty 
order on aspirin from Turkey would be likely to lead to continuation or 
recurrence of material injury to an industry in the United States 
within a reasonably foreseeable time.<SUP>2</SUP>
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
    \2\ Commissioners Carol T. Crawford and Thelma J. Askey 
dissenting, determining that revocation of the antidumping duty 
order would not be likely to lead to continuation or recurrence of 
material injury to an industry in the United States within a 
reasonably foreseeable time.
---------------------------------------------------------------------------

Background

    The Commission instituted this review on March 1, 1999 (64 FR 
10012) and determined on June 3, 1999, that it would conduct an 
expedited review (64 FR 31608).
    The Commission transmitted its determination in this investigation 
to the Secretary of Commerce on July 29, 1999. The views of the 
Commission are contained in USITC Publication 3215 (July 1999), 
entitled Aspirin from Turkey: Investigation No. 731-TA-364 (Review).

    Issued: July 30, 1999.

    By order of the Commission.
Donna R. Koehnke,
Secretary.
[FR Doc. 99-20048 Filed 8-3-99; 8:45 am]
BILLING CODE 7020-02-P